Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

Laura Oana Albulescu; Chunfang Xie; Stuart Ainsworth; Jaffer Alsolaiss; Edouard Crittenden; Charlotte A. Dawson; Rowan Softley; Keirah E. Bartlett; Robert A. Harrison; Jeroen Kool; Nicholas R. Casewell

doi:10.1038/s41467-021-24308-0

Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

Laura Oana Albulescu, Chunfang Xie, Stuart Ainsworth, Jaffer Alsolaiss, Edouard Crittenden, Charlotte A. Dawson, Rowan Softley, Keirah E. Bartlett, Robert A. Harrison, Jeroen Kool, Nicholas R. Casewell^*

^*Corresponding author for this work

AIMMS

Research output: Contribution to Journal › Comment / Letter to the editor › Academic

Abstract

The original version of this articles contained an error in Fig. 4. The graphs in panel B report the neutralization of SVSP venom by decreasing concentrations of the inhibitor nafamostat, from 150 μm to 150 nm, but the lowest concentration on the X-axis was incorrectly reported as 150 μm. This error has now been corrected on the PDF and HTML version of the article.

Original language	English
Article number	4027
Pages (from-to)	1-1
Number of pages	1
Journal	Nature Communications
Volume	12
Early online date	24 Jun 2021
DOIs	https://doi.org/10.1038/s41467-021-24308-0
Publication status	Published - 2021

Bibliographical note

Author Correction to: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite (Nature Communications, (2020), 11, (6094), 10.1038/s41467-020-19981-6).

Publisher Copyright:
© The Author(s) 2021

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Funding

Funders	Funder number
Not added	103443, MR/S00016X/1
Wellcome Trust	200517

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41467-021-24308-0

Persistent URL (handle)

Persistent link

Cite this

Albulescu, L. O., Xie, C., Ainsworth, S., Alsolaiss, J., Crittenden, E., Dawson, C. A., Softley, R., Bartlett, K. E., Harrison, R. A., Kool, J., & Casewell, N. R. (2021). Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite. Nature Communications, 12, 1-1. Article 4027. https://doi.org/10.1038/s41467-021-24308-0

@article{9c9ba1536c784f239ab2451ec279f306,

title = "Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite",

abstract = "The original version of this articles contained an error in Fig. 4. The graphs in panel B report the neutralization of SVSP venom by decreasing concentrations of the inhibitor nafamostat, from 150 μm to 150 nm, but the lowest concentration on the X-axis was incorrectly reported as 150 μm. This error has now been corrected on the PDF and HTML version of the article.",

author = "Albulescu, \{Laura Oana\} and Chunfang Xie and Stuart Ainsworth and Jaffer Alsolaiss and Edouard Crittenden and Dawson, \{Charlotte A.\} and Rowan Softley and Bartlett, \{Keirah E.\} and Harrison, \{Robert A.\} and Jeroen Kool and Casewell, \{Nicholas R.\}",

note = "Author Correction to: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite (Nature Communications, (2020), 11, (6094), 10.1038/s41467-020-19981-6). Publisher Copyright: {\textcopyright} The Author(s) 2021 Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

doi = "10.1038/s41467-021-24308-0",

language = "English",

volume = "12",

pages = "1--1",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Research",

}

Albulescu, LO, Xie, C, Ainsworth, S, Alsolaiss, J, Crittenden, E, Dawson, CA, Softley, R, Bartlett, KE, Harrison, RA, Kool, J & Casewell, NR 2021, 'Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite', Nature Communications, vol. 12, 4027, pp. 1-1. https://doi.org/10.1038/s41467-021-24308-0

TY - JOUR

T1 - Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

AU - Albulescu, Laura Oana

AU - Xie, Chunfang

AU - Ainsworth, Stuart

AU - Alsolaiss, Jaffer

AU - Crittenden, Edouard

AU - Dawson, Charlotte A.

AU - Softley, Rowan

AU - Bartlett, Keirah E.

AU - Harrison, Robert A.

AU - Kool, Jeroen

AU - Casewell, Nicholas R.

N1 - Author Correction to: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite (Nature Communications, (2020), 11, (6094), 10.1038/s41467-020-19981-6). Publisher Copyright: © The Author(s) 2021 Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021

Y1 - 2021

N2 - The original version of this articles contained an error in Fig. 4. The graphs in panel B report the neutralization of SVSP venom by decreasing concentrations of the inhibitor nafamostat, from 150 μm to 150 nm, but the lowest concentration on the X-axis was incorrectly reported as 150 μm. This error has now been corrected on the PDF and HTML version of the article.

AB - The original version of this articles contained an error in Fig. 4. The graphs in panel B report the neutralization of SVSP venom by decreasing concentrations of the inhibitor nafamostat, from 150 μm to 150 nm, but the lowest concentration on the X-axis was incorrectly reported as 150 μm. This error has now been corrected on the PDF and HTML version of the article.

UR - https://www.scopus.com/pages/publications/85108659751

UR - https://www.scopus.com/inward/citedby.url?scp=85108659751&partnerID=8YFLogxK

U2 - 10.1038/s41467-021-24308-0

DO - 10.1038/s41467-021-24308-0

M3 - Comment / Letter to the editor

AN - SCOPUS:85108659751

SN - 2041-1723

VL - 12

SP - 1

EP - 1

JO - Nature Communications

JF - Nature Communications

M1 - 4027

ER -

Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

Abstract

Bibliographical note

Funding

UN SDGs

Access to Document

Persistent URL (handle)

Other files and links

Fingerprint

A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

Cite this